SIC
TNXP icon

SJS Investment Consulting’s Tonix Pharmaceuticals TNXP Stock Holding History

SJS Investment Consulting’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
10,204
+200
+2% +$2.58K 0.01% 203
2026
Q1 		$138K Buy
+10,004
New +$154K 0.02% 179

Other funds holding TNXP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CNBT
Cornerstone National Bank & Trust Palatine, Illinois $296M AUM 12.13% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SJS Investment Consulting's TNXP Position: Q2 2026 in Review

SJS Investment Consulting increased its Tonix Pharmaceuticals (TNXP) stake by 2% in Q2 2026, buying an estimated $2.58K and bringing the position to 10,204 shares worth $130K. The position accounts for 0.01% of the portfolio, ranked #203.

SJS Investment Consulting first reported a position in TNXP in Q1 2026 and has held it in 2 quarters since. The position peaked at $138K in Q1 2026. 17 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • SJS Investment Consulting held 10,204 shares of Tonix Pharmaceuticals worth $130K as of Q2 2026.
  • SJS Investment Consulting bought 200 Tonix Pharmaceuticals shares in Q2 2026, an estimated $2.58K.
  • Tonix Pharmaceuticals made up 0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #203 holding.
  • SJS Investment Consulting first reported a position in Tonix Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • SJS Investment Consulting's Tonix Pharmaceuticals position peaked at $138K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.